Literature DB >> 19373493

Nephrogenic diabetes insipidus: treat with caution.

Thierry Boussemart1, Jacqueline Nsota, Dominique Martin-Coignard, Gérard Champion.   

Abstract

Current therapy for congenital nephrogenic diabetes insipidus consists of appropriate water intake coupled with decreased urine output obtained by means of a low-sodium diet and a combination of thiazide diuretics with renal prostaglandins inhibitors or amiloride. We report a case of congenital nephrogenic diabetes insipidus that was complicated by paradoxical water intoxication secondary to liberal water intake and the initiation of hydrochlorothiazide and indomethacin combination therapy. This report emphasizes the importance of evaluating the water balance and of a quick response with strict protocols following the initiation of indomethacin and thiazide diuretics in nephrogenic diabetes insipidus.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19373493     DOI: 10.1007/s00467-009-1187-9

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  13 in total

Review 1.  Back to basics: congenital nephrogenic diabetes insipidus.

Authors:  Michael A Linshaw
Journal:  Pediatr Rev       Date:  2007-10

2.  Amiloride-hydrochlorothiazide versus indomethacin-hydrochlorothiazide in the treatment of nephrogenic diabetes insipidus.

Authors:  N Knoers; L A Monnens
Journal:  J Pediatr       Date:  1990-09       Impact factor: 4.406

Review 3.  The perioperative challenge of nephrogenic diabetes insipidus: a multidisciplinary approach.

Authors:  S J Moug; R F McKee; D St J O'Reilly; S Noble; M Boulton-Jones
Journal:  Surgeon       Date:  2005-04       Impact factor: 2.392

Review 4.  Hyponatremia: pathophysiology and treatment, a pediatric perspective.

Authors:  A B Gruskin; A Sarnaik
Journal:  Pediatr Nephrol       Date:  1992-05       Impact factor: 3.714

5.  Amelioration of polyuria in nephrogenic diabetes insipidus due to aquaporin-2 deficiency.

Authors:  Z Hochberg; L Even; A Danon
Journal:  Clin Endocrinol (Oxf)       Date:  1998-07       Impact factor: 3.478

6.  Clinical characteristics of eight patients with congenital nephrogenic diabetes insipidus.

Authors:  Haruo Mizuno; Yukari Sugiyama; Yoichiro Ohro; Hiroki Imamine; Masanori Kobayashi; Sei Sasaki; Sinichi Uchida; Hajime Togari
Journal:  Endocrine       Date:  2004-06       Impact factor: 3.633

7.  Antenatal Bartter's syndrome: why is this not a lethal condition?

Authors:  D Bockenhauer; M Cruwys; R Kleta; L F Halperin; P Wildgoose; T Souma; N Nukiwa; S Cheema-Dhadli; C K Chong; K S Kamel; M R Davids; M L Halperin
Journal:  QJM       Date:  2008-10-01

8.  Response to indomethacin and hydrochlorothiazide in nephrogenic diabetes insipidus.

Authors:  L Monnens; A Jonkman; C Thomas
Journal:  Clin Sci (Lond)       Date:  1984-06       Impact factor: 6.124

9.  Comparative therapeutic benefit of indomethacin, hydrochlorothiazide, and acetyl-salicylic acid in a patient with nephrogenic diabetes insipidus.

Authors:  H Vierhapper; J Jörg; L Favre; M B Vallotton; W Waldhäusl
Journal:  Acta Endocrinol (Copenh)       Date:  1984-07

10.  The renin-aldosterone system in nephrogenic diabetes insipidus and the influence of hydrochlorothiazide and indomethacin.

Authors:  O Andersen; B B Jacobsen
Journal:  Acta Paediatr Scand       Date:  1983-09
View more
  5 in total

1.  Nephrogenic diabetes insipidus: the key element of paradoxical hyponatremia.

Authors:  Montserrat Anton-Gamero; Elena Garcia-Martinez; Joaquín Fernandez-Ramos; Mónica Rodríguez-Salas; Mercedes Gil-Campos
Journal:  Pediatr Nephrol       Date:  2009-07-11       Impact factor: 3.714

Review 2.  Pathophysiology, diagnosis and management of nephrogenic diabetes insipidus.

Authors:  Detlef Bockenhauer; Daniel G Bichet
Journal:  Nat Rev Nephrol       Date:  2015-06-16       Impact factor: 28.314

3.  Acetazolamide Attenuates Lithium-Induced Nephrogenic Diabetes Insipidus.

Authors:  Theun de Groot; Anne P Sinke; Marleen L A Kortenoeven; Mohammad Alsady; Ruben Baumgarten; Olivier Devuyst; Johannes Loffing; Jack F Wetzels; Peter M T Deen
Journal:  J Am Soc Nephrol       Date:  2015-11-16       Impact factor: 10.121

4.  Severe congenital nephrogenic diabetes insipidus in a compound heterozygote with a new large deletion of the AQP2 gene. A case report.

Authors:  Ramón Peces; Rocío Mena; Carlos Peces; Fernando Santos-Simarro; Luis Fernández; Sara Afonso; Pablo Lapunzina; Rafael Selgas; Julián Nevado
Journal:  Mol Genet Genomic Med       Date:  2019-02-19       Impact factor: 2.183

5.  Case Report: A Case of Congenital Nephrogenic Diabetes Insipidus Caused by Thr273Met Mutation in Arginine Vasopressin Receptor 2.

Authors:  Li Huang; Lina Ma; Linjing Li; Jiajia Luo; Tianhong Sun
Journal:  Front Pediatr       Date:  2021-07-15       Impact factor: 3.418

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.